IRRC CORPORATION

Press Releases IRRC Corporation

Equities

7325

JP3105230001

Delayed Japan Exchange Other stock markets 07:00:00 13/05/2024 BST			5-day change	1st Jan Change
735 ^JPY	+1.38%		+2.37%	+13.78%

02-19	Tranche Update on IRRC Corporation's Equity Buyback Plan announced on August 18, 2023.	CI
02-16	IRRC Corporation's Equity Buyback announced on August 18, 2023, has closed with 200,000 shares, representing 2.39% for ¥140.90 million.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Henlius Biotech, Inc. - Results from Four Phase 1/2 Clinical Trials of Henlius Innovative Products Released at 2023 ESMO Asia	12-05	AQ
CStone Announces Publication of GEMSTONE-201 Study Results for Sugemalimab Monotherapy in the Treatment of Relapsed, Refractory Extranodal NK/T-Cell Lymphoma in Journal of Clinical Oncology	31/03/23	AQ
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan	21/11/22	AQ
CStone presents clinical results of sugemalimab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma via an oral abstract session at ASCO 2022	06/06/22	AQ
IRRC : Pennsylvania Takes Next Step Toward Cap-and-Trade Amid Resistance	30/07/21	AQ
Worth Another Look: Regional Greenhouse Gas Initiative (RGGI)	14/07/21	AQ
IRRC : New Overtime Pay Regulation In Pennsylvania May Create Obligations For Employers Beyond Federal Requirements	25/02/20	AQ
Gilead Sciences : U.S. FDA Grants Priority Review for Kite's KTE-X19 Biologics License Application in Relapsed or Refractory Mantle Cell Lymphoma	11/02/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer